Research To Practice

•

Kanal • 10 program

Vetenskap

Vetenskap

Varje månad
Vetenskap

Vetenskap

Varje vecka
Vetenskap

Vetenskap

Varje vecka
Vetenskap

Vetenskap

Varje månad
Vetenskap

Vetenskap

Varje vecka
Vetenskap

Vetenskap

27 feb.
Vetenskap

Vetenskap

Varje månad

−3 D

Breast Cancer — 5-Minute Journal Club Issue 2 with Dr Lajos Pusztai: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays

Dr Lajos Pusztai from Yale Cancer Center in New Haven, Connecticut, discusses recent developments with circulating tumor DNA assays in the management of breast cancer. CME information and select publications here.

−3 d

•

30 min
27 JAN.

Endocrine-Based Therapy for HR-Positive Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series

Dr Angela DeMichele from the Abramson Cancer Center in Philadelphia, Pennsylvania, Dr Komal Jhaveri from Memorial Sloan Kettering Cancer Center in New York, New York, Dr Erica Mayer from Dana-Farber Cancer Institute in Boston, Massachusetts, Dr Hope S Rugo from City of Hope Comprehensive Cancer Center in Duarte, California, and Dr Seth Wander from Massachusetts General Hospital in Boston discuss real-world cases and recent clinical data surrounding the management of HR-positive breast cancer. CME information and select publications here.

27 jan.

•

2 tim 1 min
13 MARS

CD19 x CD3 BiTEs for Acute Lymphoblastic Leukemia — An Interview with Dr Bijal Shah

Dr Bijal Shah from Moffitt Cancer Center in Tampa, Florida, discusses the role of BiTEs in the management of ALL. CME information and select publications here.

13 mars

•

1 tim 3 min
7 MARS

Ovarian Cancer — Year in Review Series on Relevant New Datasets and Advances

Prof Nicoletta Colombo and Dr Kathleen N Moore discuss the selection and sequencing of therapy for patients with ovarian cancer and summarize major advances in the treatment landscape over the past year. CME information and select publications here.

7 mars

•

56 min
7 MARS

Ovarian Cancer — Year in Review Series on Relevant New Datasets and Advances

Prof Nicoletta Colombo and Dr Kathleen N Moore discuss the selection and sequencing of therapy for patients with ovarian cancer and summarize major advances in the treatment landscape over the past year. CME information and select publications here.

7 mars

•

56 min
4 MARS

Immune Thrombocytopenia — Microlearning Activity 1 with Dr Hanny Al-Samkari: ASH 2025 Review

Dr Hanny Al-Samkari from Massachusetts General Hospital in Boston discusses recent developments from the ASH 2025 Annual Meeting involving the use of Bruton tyrosine kinase inhibitors and BAFF-R antagonists in the treatment of immune thrombocytopenia. CME information and select publications here.

4 mars

•

24 min
−5 D

Desmoid Tumors — Microlearning Activity 1 with Dr Ravin Ratan

Dr Ravin Ratan from The University of Texas MD Anderson Cancer Center in Houston discusses available clinical data with treatment approaches for desmoid tumors, alongside clinical cases illustrating real-world application. CME information and select publications here.

−5 d

•

17 min
9 MARS

Immune Thrombocytopenia — Microlearning Activity 2 with Dr Hanny Al-Samkari: ASH 2025 Review

Dr Hanny Al-Samkari from Massachusetts General Hospital in Boston discusses recent developments from the ASH 2025 Annual Meeting involving the use of Bruton tyrosine kinase inhibitors and BAFF-R antagonists in the treatment of immune thrombocytopenia. CME information and select publications here.

9 mars

•

19 min
2023-08-04

Oncology Today with Dr Neil Love: Special Edition — Key Presentations from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Ovarian Cancer Issue

Dr David O’Malley from The James Cancer Center in Columbus, Ohio, discusses recent advances in the management of ovarian cancer, including presentations from ASCO 2023.

2023-08-04

•

57 min
2022-07-21 · VIDEO

Cholangiocarcinoma | Oncology Today with Dr Neil Love: Management of Cholangiocarcinoma and Other Biliary Tract Cancers

Featuring an interview with Professor Juan Valle, including the following topics: Immunotherapy for patients with biliary tract cancers (BTCs) (0:00) Etiology and presentation of and recent advances in the management of cholangiocarcinoma (4:18) Targeting FGFR alterations in cholangiocarcinoma and other BTCs (12:47) Spectrum and management of toxicities associated with FGFR inhibitors (19:33) Targeting driver mutations beyond FGFR (28:16) Case: A man in his early 60s with intrahepatic cholangiocarcinoma, an FGFR2 fusion and an IDH1 R132C mutation (35:53) Case: A woman in her early 60s with intrahepatic cholangiocarcinoma and an IDH1 mutation that did not respond to third-line ivosidenib (41:49) Case: A woman in her early 60s with gallbladder cancer who received first-line chemotherapy with pembrolizumab (46:15) CME information and select publications

2022-07-21 · Video

•

50 min

CME education for oncology clinicians. Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.

Leverantör